{"log_id": 2118086862747441700, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 0.011833, "average": 0.946983, "min": 0.643873}, "location": {"width": 905, "top": 358, "height": 80, "left": 406}, "words": "甲氨蝶呤停药后恶性淋巴瘤可能消退,上述情况可发生在接受低剂量甲氨"}, {"probability": {"variance": 0.002486, "average": 0.97977, "min": 0.728727}, "location": {"width": 909, "top": 397, "height": 80, "left": 402}, "words": "蝶呤治疗的患者中,这些患者可能不需要细胞毒药物治疗,应首先停止使"}, {"probability": {"variance": 0.009966, "average": 0.957726, "min": 0.560293}, "location": {"width": 706, "top": 432, "height": 75, "left": 400}, "words": "用甲氨蝶呤,如果淋巴瘤没有消退须制定适当的治疗方案"}, {"probability": {"variance": 0.008965, "average": 0.963924, "min": 0.553759}, "location": {"width": 912, "top": 484, "height": 82, "left": 395}, "words": "潜在的致死性的机会性感染,特别是卡氏肺囊虫性肺炎,可以发生在甲氨"}, {"probability": {"variance": 0.001465, "average": 0.982824, "min": 0.889162}, "location": {"width": 201, "top": 525, "height": 43, "left": 395}, "words": "蝶吟治疗过程中"}, {"probability": {"variance": 0.033231, "average": 0.898713, "min": 0.438522}, "location": {"width": 955, "top": 569, "height": 93, "left": 390}, "words": "使用甲氨蝶呤的同时进行鼓射治疗可能会增加软组织坏环死的风"}, {"probability": {"variance": 0, "average": 0.999596, "min": 0.999596}, "location": {"width": 34, "top": 617, "height": 29, "left": 390}, "words": "险"}, {"probability": {"variance": 0.004894, "average": 0.960221, "min": 0.742885}, "location": {"width": 340, "top": 663, "height": 57, "left": 388}, "words": "肾功能损害足常见的禁忌症"}, {"probability": {"variance": 0.015358, "average": 0.938116, "min": 0.532828}, "location": {"width": 973, "top": 704, "height": 105, "left": 381}, "words": "腹泻和溃疡性口腔炎是常见的毒性反应,需要中断治疗。此可能发射"}, {"probability": {"variance": 0.023522, "average": 0.950772, "min": 0.419687}, "location": {"width": 365, "top": 754, "height": 54, "left": 381}, "words": "出血性肠炎和致死性的肠穿"}, {"probability": {"variance": 0.014709, "average": 0.944597, "min": 0.398107}, "location": {"width": 898, "top": 804, "height": 84, "left": 390}, "words": "曾有报道输注甲氨蝶呤(通常为大剂量)的同时使用非体类抗炎药"}, {"probability": {"variance": 0.002855, "average": 0.976186, "min": 0.72763}, "location": {"width": 889, "top": 843, "height": 80, "left": 397}, "words": " NSAIDS)后出现不可预知的严重的(有时是致死的)骨髓抑制、再生障"}, {"probability": {"variance": 0.032327, "average": 0.925417, "min": 0.391306}, "location": {"width": 288, "top": 880, "height": 50, "left": 377}, "words": "性贫血和胃肠道毒性"}, {"probability": {"variance": 0.020416, "average": 0.948669, "min": 0.383983}, "location": {"width": 921, "top": 928, "height": 82, "left": 358}, "words": "甲氨蝶呤诱发的肺部疾病,包括急性或慢性的间质性肺炎是一种在的危险"}, {"probability": {"variance": 0.002737, "average": 0.972911, "min": 0.783385}, "location": {"width": 909, "top": 967, "height": 80, "left": 370}, "words": "损害,有报道在低剂量用药时它们可能急性发作于治疗的任何时期。这种"}, {"probability": {"variance": 0.001945, "average": 0.983019, "min": 0.797187}, "location": {"width": 909, "top": 1001, "height": 82, "left": 368}, "words": "损伤并不都是完全可逆的,并且有因此死亡的报道。如出现肺部症状(尤"}, {"probability": {"variance": 0.011407, "average": 0.955231, "min": 0.484977}, "location": {"width": 909, "top": 1040, "height": 80, "left": 365}, "words": "其是无痰性干咳、呼吸困难)可能需要中断治疗并且给予仔细的检查。肺"}, {"probability": {"variance": 0.005725, "average": 0.963348, "min": 0.631771}, "location": {"width": 905, "top": 1076, "height": 80, "left": 365}, "words": "部损伤在任何剂量下甚至低至每周75mg剂量都会发生。需要排除感染(包"}, {"probability": {"variance": 0.024124, "average": 0.926704, "min": 0.496869}, "location": {"width": 509, "top": 1113, "height": 59, "left": 363}, "words": "括肺炎),需要密切监测患者的肺部症状"}, {"probability": {"variance": 0.013272, "average": 0.924779, "min": 0.573468}, "location": {"width": 1122, "top": 1159, "height": 100, "left": 304}, "words": "1.大剂量甲氨蝶呤结合亚叶酸(叶酸钙)解救用于特定的肿瘤性疾病的实验 GTRIBUT"}, {"probability": {"variance": 0.017552, "average": 0.948795, "min": 0.425421}, "location": {"width": 992, "top": 1191, "height": 98, "left": 356}, "words": "性治疗,上述操作程序尚在研究中并且是危险的。在没有必要的专业持术中"}, {"probability": {"variance": 0.008562, "average": 0.957421, "min": 0.53081}, "location": {"width": 912, "top": 1234, "height": 82, "left": 358}, "words": "和资源组合的设施下不能尝试使用大剂量甲氨蝶呤。有必要查阅最新发表"}, {"probability": {"variance": 0.001134, "average": 0.963869, "min": 0.916383}, "location": {"width": 86, "top": 1275, "height": 34, "left": 356}, "words": "的文献"}, {"probability": {"variance": 8.6e-05, "average": 0.991244, "min": 0.973125}, "location": {"width": 155, "top": 1371, "height": 45, "left": 290}, "words": "【注意事项】"}, {"probability": {"variance": 0.00011, "average": 0.988444, "min": 0.970934}, "location": {"width": 256, "top": 1449, "height": 43, "left": 283}, "words": "在下述情况下需慎用"}, {"probability": {"variance": 0.00025, "average": 0.990507, "min": 0.929608}, "location": {"width": 976, "top": 1483, "height": 86, "left": 276}, "words": "甲氨蝶呤只能由有抗代谢药物化疗经验的医生使用,如果是非肿瘤的情况则必须"}, {"probability": {"variance": 0.00144, "average": 0.982017, "min": 0.822933}, "location": {"width": 973, "top": 1520, "height": 89, "left": 276}, "words": "专科医生使用。因为有致命或严重的毒性反应的可能,医生必须充分告知患者"}, {"probability": {"variance": 0.010614, "average": 0.953993, "min": 0.571505}, "location": {"width": 976, "top": 1559, "height": 89, "left": 272}, "words": "存在的风险,并且应该在其监督下用药。应由适当的设施来处理可能发生的并发"}, {"probability": {"variance": 0, "average": 0.982433, "min": 0.982433}, "location": {"width": 34, "top": 1602, "height": 32, "left": 272}, "words": "症"}, {"probability": {"variance": 0.010717, "average": 0.948994, "min": 0.606797}, "location": {"width": 955, "top": 1636, "height": 89, "left": 269}, "words": "在大剂量使用或药物排泄减弱(肾功能损害,胸腔积液,朦求的情况下,"}, {"probability": {"variance": 0.01474, "average": 0.939314, "min": 0.408099}, "location": {"width": 955, "top": 1673, "height": 91, "left": 267}, "words": "须严密监测药物毒性反应。曾有过关于使用甲氨蝶吟治疗性肿避和银屑病后"}, {"probability": {"variance": 0.002804, "average": 0.967564, "min": 0.841844}, "location": {"width": 196, "top": 1714, "height": 48, "left": 267}, "words": "导致死亡的报道"}, {"probability": {"variance": 0.02322, "average": 0.931775, "min": 0.356376}, "location": {"width": 923, "top": 1792, "height": 82, "left": 310}, "words": "在治疗银屑病时甲氨蝶吟仅用于对其它治疗方式疗效不明显的严重固"}, {"probability": {"variance": 0.007887, "average": 0.975901, "min": 0.511953}, "location": {"width": 823, "top": 1831, "height": 77, "left": 308}, "words": "和致残性病例,并且只能在组织活检和或适当会诊明确诊断后使用"}, {"probability": {"variance": 0.018215, "average": 0.945812, "min": 0.480669}, "location": {"width": 896, "top": 1867, "height": 82, "left": 306}, "words": "甲氨蝶呤可以引起显著的骨髓抑料、贫血、再生障碍性贫血、白细胞减少"}, {"probability": {"variance": 0.006369, "average": 0.96925, "min": 0.578477}, "location": {"width": 919, "top": 1904, "height": 89, "left": 304}, "words": "中性粒细胞减少、血小板减少和出血。甲氨蝶呤可能具有肝脏毒性,特别是"}, {"probability": {"variance": 0.00378, "average": 0.974869, "min": 0.727148}, "location": {"width": 919, "top": 1945, "height": 84, "left": 301}, "words": "在大剂量或长时间治疗的情况下。曾报道有肝萎缩、肝坏死、肝硬化、脂肪"}, {"probability": {"variance": 0.032026, "average": 0.883409, "min": 0.477779}, "location": {"width": 162, "top": 2034, "height": 32, "left": 656}, "words": "7夏,共15页"}], "language": 3}